Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Drugmakers Warnings News Monitoring

Get by Email • RSS

Published on Mar 24, 2025

23andMe shares tumble after bankruptcy filing and California attorney general’s privacy warning

South San Francisco-based genetic testing venture 23andMe saw its shares plunge more than 50% Monday after the company announced it had filed for Chapter 11 bankruptcy protection. The company announced Sunday it will seek court authorization to sell its …

Source: Los Angeles Times - Center-left
Published on 06:33 GMT

Bayer ordered to pay €1.9 billion by US court in Roundup cancer case

Pharmaceutical company Bayer took over weed killer Roundup in its acquisition of US agrochemical company Monsanto back in 2018. However, it has since been hit with thousands of cancer-related Roundup cases. German agricultural and pharmaceutical giant …

Source: Euronews - Neutral
Published on 00:12 GMT

23andMe files for bankruptcy, putting customers’ genetic data at risk

The genetic testing company 23andMe has begun Chapter 11 bankruptcy proceedings, alarming regulators and privacy advocates who are warning customers to delete genetic information retained by the company. Chapter 11 is a bankruptcy process focused on …

Source: The Record - Neutral
Published on Mar 24, 2025

Drugs to treat Parkinson’s and restless leg syndrome can lead to risky behaviour

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common. But a BBC investigation has highlighted that some drug treatments for restless leg syndrome and …

Source: Scroll.in - Center-left
Published on Mar 24, 2025

Georgia jury awards landowner $2.1B in Roundup cancer case

A jury in Georgia has ordered the manufacturer of a popular weedkiller to pay nearly $2.1 billion to a customer who said that the product caused him to develop cancer. The verdict against agribusiness giant Monsanto, now owned by the German pharmaceutical …

Source: E&E News - Neutral
Published on Mar 24, 2025

5 years of the COVID-19 pandemic: The response of the <em>World Socialist Web Site</em>

We urge our readers to review the comprehensive timeline accompanying this statement, which is part of the World Socialist Web Site’s commemoration of the five-year anniversary of the start of the COVID-19 pandemic. To get involved in the fight for a …

Source: World Socialist Web Site - Left-wing
Published on Mar 24, 2025

23andMe files for bankruptcy. What happens to all the DNA data?

Embattled genetic testing company 23andMe, once valued at $6 billion, filed for Chapter 11 bankruptcy protection in Missouri federal court on Sunday night. The company's CEO, Anne Wojcicki, has resigned from her role as chief executive effective …

Source: NBC 4 - New York - Neutral
Published on Mar 24, 2025

23andMe is for sale — and so are 15 million people's genetic records

After a brutal data breach and a wave of lawsuits, 23andMe filed for Chapter 11 bankruptcy — and now, the consumer genetics company is looking for a buyer. On the table are the business, the brand, and the DNA profiles of more than 15 million users. The …

Source: Mashable SE Asia - Left-wing
Published on Mar 24, 2025

Million-Dollar-Plus Settlements of 2024

Following are settlements of at least $1 million reached in 2024 and reported to Virginia Lawyers Weekly. $85 million — Pharmaceutical co. agrees to resolve fraud suit; settlement considered one of largest on record Type of action: Health care fraud Court: …

Source: Virginia Lawyers Weekly - Label Pending
Published on Mar 24, 2025

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate ...

Initial distribution of Emrosi to pharmacies ongoing First prescriptions of Emrosi filled SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on Mar 24, 2025

Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable ...

NASHVILLE, Tenn.–(BUSINESS WIRE)–$HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that the Centers for Medicare & Medicaid Services (CMS) has approved Harrow’s transitional pass-through application …

Source: The AI Journal - Label Pending
Published on Mar 20, 2025

South Africa's Aspen hit with warning letter chiding the continent's largest drugmaker over sterility issues

After rising to prominence during the COVID-19 pandemic, South African drugmaker Aspen Pharmacare has landed in the FDA's crosshairs thanks to a recent inspection that uncovered problems at one of the company's production plants. Aspen, the …

Source: Fierce Pharma - Neutral
Published on Mar 24, 2025

UK life sciences losing out on £15bn a year to overseas rivals

Britain’s life science sector has missed out on an estimated £15 billion a year over the past decade due to a decline in its international competitiveness, a report warns. The sector has been designated one of the government’s eight key growth drivers as …

Source: The Times - Center-right
Published on Mar 24, 2025

Trump escalating US economic war with looming “reciprocal tariffs”

At the beginning of next month US President Donald Trump’s economic war against the rest of the world will be intensified when he receives a report on the imposition of so-called “reciprocal tariffs.” The designation creates the impression that US tariffs …

Source: World Socialist Web Site - Left-wing
Published on Mar 23, 2025

Mounjaro Weight Loss Drug Launched In India - Price? How It Works? Side Effects?

Eli Lilly is the first leading pharmaceutical company to provide a GLP-1/GIP dual-action weight-loss and diabetes medication in india with the launch of Mounjaro (Tirzepatide). Given that obesity and diabetes are major issues in india, Eli Lilly is …

Source: India Herald - Uncategorized
Published on Mar 22, 2025

Why MultiChoice Matters

Two weeks ago, a Federal High Court in Abuja issued an injunction that prevents the Federal Competition and Consumer FCCPC from taking action against MultiChoice Nigeria Limited, the pay television service provider. This development followed MultiChoice’s …

Source: The Guardian (Nigeria) - Uncategorized
Published on Mar 21, 2025

Taste Matters: Flavoring Agents and Taste Modulation Strategies in Drug Development

There is a proven correlation between patient compliance and the palatability of medicine; a bitter taste or an unpleasant texture can lead to reduced adherence to prescribed treatments, potentially compromising the effectiveness of the therapy. There is …

Source: American Pharmaceutical Review - Neutral
Published on Mar 21, 2025

Call to end experiments on caged monkeys bred at Monash University facility

In a small country town east of Melbourne, monkeys are bred in a university laboratory and used for experiments to improve health and medical outcomes for people around the world. Warning: This article describes procedures some readers may find distressing …

Source: ABC (Australian Broadcasting Corporation) - Neutral
Published on Mar 21, 2025

Trading Day: Consolidating while awaiting tariff clarity

By Jamie McGeever ORLANDO, Florida (Reuters) - TRADING DAY Late push lifts Nasdaq to first gain in 5 weeks Many of the world's major central banks sent a strong message this week that the uncertainty caused by U.S. President Donald Trump's trade …

Source: Yahoo Finance - Label Pending

06 days 16:03:51

Featured Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 11:30 GMT

Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other ...

Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic Dermatitis Third Quoin Patent Application for Netherton Syndrome If Granted Company Would have Patent Protection for QRX003 for Netherton …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...
Published on March 25, 2025 - 11:30 GMT

Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR

Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and the risk of long COVID due to a longer treatment regimen Preparations are underway for FDA interactions and initiation of …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on March 25, 2025 - 11:30 GMT

Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.

NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle invasive bladder cancer (NMIBC, U.S. prevalence of ~600,000 patients, with ~62,000 newly diagnosed patients …

Distribution channels: Companies, Technology ...
Published on March 25, 2025 - 11:00 GMT

NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel ...

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the neuromuscular …

Distribution channels: Media, Advertising & PR, Technology ...

Published on March 25, 2025 - 10:01 GMT

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 4WARD trial protocol refined, increasing confidence in successful outcome 2024 …

Distribution channels:
Published on March 25, 2025 - 06:30 GMT

Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan

- Alumis to receive $40 million in upfront and near-term co-development payments, with potential for approximately $140 million in additional milestone and field option payments, plus tiered royalties on future sales -Deal underscores the commercial …

Distribution channels: Technology ...
Published on March 25, 2025 - 06:00 GMT

NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel ...

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the neuromuscular …

Distribution channels: Media, Advertising & PR, Technology ...
Published on March 25, 2025 - 03:13 GMT

Lawsuit Notice: Investors who hold Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares should contact the Shareholders ...

SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Investors who purchased shares of Regeneron Pharmaceuticals, …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 796,913,499 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 11:55 GMT

Saving Lives: Angela Buckalew’s Mission to Improve AED Access, Training, and Compatibility

Angela Buckalew is breaking barriers in AED training and technology, ensuring more people are prepared to act in a cardiac emergency. CINCINNATI, OH, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Sudden cardiac arrest (SCA) is one of the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 25, 2025 - 11:53 GMT

37% Drop in UK Work Visa Approvals: Get Sponsored Job Reveals Key Findings and Strategies for Job Seekers

UK work visa approvals dropped 37%. Get Sponsored Job (GSJ) advises targeting high-demand sectors, tailoring CVs, and networking to boost job search success. LONDON, UNITED KINGDOM, March 25, 2025 /⁨EINPresswire.com⁩/ -- The UK job market is …

Distribution channels: Business & Economy, Education ...
Published on March 25, 2025 - 11:30 GMT

Mobility City's Technician Network, the Largest HME Repair & Delivery Network, is Now an Accredited Exemplary Provider

Mobility City's franchise system, with the largest HME repair and delivery Technician Network in the US, is now a CMS approved Exemplary Provider BOCA RATON, FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Mobility City Holdings Inc, …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:30 GMT

Foreign Aid Bridge Fund Donations Surpass $1 Million

Emergency Funding Fuels Life-Saving Relief for Frontline Organizations Amid Rising Global Crises WASHINGTON, RI, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Foreign Aid Bridge Fund has surpassed $1 million in donations just over a …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

Enkrypt AI Launches New Multimodal AI Security Solution to Safeguard Text, Image, and Voice AI Systems

Innovative solution secures multimodal AI systems from emerging security, bias, and compliance risks BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Enkrypt AI, a leader in AI security and compliance – is proud to announce the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 25, 2025 - 11:00 GMT

Dean Melissa Perry appointed to prestigious National Academies of Sciences, Engineering, and Medicine Committee

Perry appointed to NASEM Committee on Clinical Follow-Up and Care for Those Impacted by the JP-5 Releases at Red Hill. FAIRFAX, VA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- As a widely respected researcher and public health leader, …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

LarmorBio Announces Addition of Multiple New Board Members and Senior Executive Hires

Company Prepares to Scale Business with Proprietary Microscale Magnetic Resonance Technology BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

CMTA’s $300K Investment in CRISPR for CMT2A

CMTA invests $300K in CRISPR gene editing for CMT2A at UCSF’s Gladstone Institutes, targeting MFN2 mutations to restore nerve function. GLENOLDEN, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:45 GMT

Feroot Launches PaymentGuard AI: Automated PCI DSS 4 Compliance for Websites with E-commerce Payment Webpages.

PaymentGuard AI by Feroot Security: Automating PCI DSS 4 Compliance with Requirements 6.4.3 and 11.6.1 for SAQ D and SAQ A-EP E-Commerce Merchants. TORONTO, CANADA, March 25, 2025 /⁨EINPresswire.com⁩/ -- Feroot Security, a leader in cybersecurity …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:45 GMT

PUSH for Empowered Pregnancy Launches #MomentForStillness to Honor Babies Born Still and Demand Urgent Action

A Nationwide Call to Address Preventable Stillbirths Begins March 25th at Noon ET NEW YORK, NY, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PUSH for Empowered Pregnancy is launching the #MomentForStillness campaign at noon ET on Tuesday, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:18 GMT

TravelingWiki Foundation Launches 'Card For a Cause' to Leverage Sports Cards for Free Non Visible Disability Resources

TravelingWiki Now Offers Free Resources in English, Spanish, French, German, Mandarin, Japanese, Hebrew, Arabic, Portuguese, Hindi, Twi, Vietnamese & Russian DES MOINES, IA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- TravelingWiki …

Distribution channels: Aviation & Aerospace Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:00 GMT

PhenoBiome Welcomes New Leadership and Validates Breakthrough Microbiome Modulation

Brian Russon Named CEO, Kait Mikes Appointed COO as Company Advances Clinical Validation of Predictive Platform PALM SPRINGS, CA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PhenoBiome, Inc., a pioneering leader in personalized …

Distribution channels: Business & Economy, Food & Beverage Industry ...
Published on March 25, 2025 - 09:45 GMT

Florida Mesothelioma Victims Center Has Endorsed the Gori Law Firm for a Former Power Plant Worker with Just Diagnosed ...

TAMPA , FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Florida Mesothelioma Victims Center says, "We have endorsed, and we highly recommend the Gori Law Firm for a former power plant worker with just diagnosed mesothelioma or …

Distribution channels: Automotive Industry, Building & Construction Industry ...
Published on March 25, 2025 - 09:43 GMT

OmnySense to Target Oncology Patients as Initial Focus for Its Transformative Personal Health-Assessment Solution

19m Americans have cancer. Unplanned acute visits drive nearly half the costs-creating a major unmet need and opportunity for innovative solutions TEL AVIV, ISRAEL, March 25, 2025 /⁨EINPresswire.com⁩/ -- OmnySense, an innovative digital health …

Distribution channels: Banking, Finance & Investment Industry, Emergency Services ...
Published on March 25, 2025 - 08:17 GMT

RSU Research Week Opening Session highlights the interaction between medicine, technology, and behavioural science

RSU Research Week 2025 opened on 24 March with an ambitious plenary session focusing on the role of research, technology, and the human factor in healthcare. RIGA, LATVIA, March 25, 2025 /⁨EINPresswire.com⁩/ -- RSU Research Week 2025 opened on 24 …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 08:09 GMT

Dan Pitulia Appointed as Group CEO of the Atlas Antibodies Group

The Board of Atlas Antibodies Group is pleased to announce the appointment of Dan Pitulia as the new Group Chief Executive Officer (CEO). STOCKHOLM, SWEDEN, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Board of Atlas Antibodies Group is pleased to announce …

Distribution channels: Business & Economy, Chemical Industry ...
Published on March 25, 2025 - 07:36 GMT

A' Wellness, Health Promotion, and Preventive Care Design Award Announces Comprehensive Prize Package for 2024

The prestigious A' Wellness, Health Promotion, and Preventive Care Design Award reveals an extensive array of benefits for 2024 competition laureates COMO, CO, ITALY, March 25, 2025 /⁨EINPresswire.com⁩/ -- The A' Wellness, Health Promotion …

Distribution channels: Business & Economy, Consumer Goods ...
Published on March 25, 2025 - 05:24 GMT

Unlocking the Potential of Tofacitinib: New Frontiers in Treating Skin Disorders

BRADENTON, FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Skin disease related to immune system problems can be a challenge to treat. A new drug, Tofacitinib has gained attention for its therapeutic effects in autoimmune and inflammatory …

Distribution channels: Beauty & Hair Care, Education ...
Published on March 25, 2025 - 05:08 GMT

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA: Empowering young children with autism through individualized therapy. LANCASTER, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Acclaim Autism is thrilled to …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:30 GMT

Cognition Therapeutics to Report Biomarker Results from Phase 2 SHINE Study in Mild-to-Moderate Alzheimer’s Disease in ...

PURCHASE, N.Y., March 25, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, will be presenting biomarker results from the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...